Amanote Research
Register
Sign In
NEW FIXED COMBINATION OF LONG-ACTING ANTICHOLINERGIC GLYCOPYRRONIUM BROMIDE AND Β2-Agonist OF INDACATEROL: PROSPECTS OF COBD THERAPY
Medical Council
doi 10.21518/2079-701x-2016-15-11-16
Full Text
Open PDF
Abstract
Available in
full text
Date
January 1, 2016
Authors
S. N. AVDEEV
Publisher
Remedium, Ltd.
Related search
Profile of Inhaled Glycopyrronium Bromide as Monotherapy and in Fixed-Dose Combination With Indacaterol Maleate for the Treatment of COPD
International Journal of COPD
Environmental
Public Health
Health Policy
Medicine
Pulmonary
Respiratory Medicine
Occupational Health
Respiratory and Cardiovascular Effects of Combined Therapy With Indacaterol and Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease
Pulmonologiya
Pulmonary
Respiratory Medicine
Efficacy of a New Once-Daily Long-Acting Inhaled 2-Agonist Indacaterol Versus Twice-Daily Formoterol in COPD
Thorax
Pulmonary
Respiratory Medicine
Comparative Efficacy of Umeclidinium Bromide Versus Other Long-Acting Anticholinergic Monotherapies as Treatments for Copd Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effective Management of COPD in Primary Care — The Role of Long-Acting Beta Agonist/Inhaled Corticosteroid Combination Therapy
Primary Care Respiratory Journal
Abediterol (LAS100977), a Novel Long-Acting Β2-Agonist: Efficacy, Safety and Tolerability in Persistent Asthma
Respiratory Medicine
Pulmonary
Respiratory Medicine
Systematic Review and Network Meta-Analysis of the Efficacy and Safety of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Comparison With Other Long-Acting Muscarinic Antagonist/Long-Acting Β2-Agonist Fixed-Dose Combinations in COPD
Therapeutic Advances in Respiratory Disease
Pulmonary
Respiratory Medicine
Pharmacology
Effects of Roflumilast in COPD Patients Receiving Inhaled Corticosteroid/Long-Acting Β2-Agonist Fixed-Dose Combination: RE2SPOND Rationale and Study Design
International Journal of COPD
Environmental
Public Health
Health Policy
Medicine
Pulmonary
Respiratory Medicine
Occupational Health
Changing Patterns of Asthma Medication Use Related to US Food and Drug Administration Long-Acting Β2-Agonist Regulation From 2005-2011
Journal of Allergy and Clinical Immunology
Allergy
Immunology
